UltiMed, Inc. begins manufacturing pen needles in the U.S.

  • November 12, 2011
  • Corporate News

St. Paul, MN – November 11, 2011 – UltiMed, Inc. announced the beginning of the manufacture of pen needles at its DeSmet, South Dakota facilities.

Pen needles are used on pen injectors. Pen injectors are designed for more convenient injection of insulin and other self injected medications. Pen injection is the most popular means of administrating medications in many of the world’s developed areas including Europe, Canada and Asia. Pen injection is increasing being used by self injectors in the United States.

UltiMed designed its manufacturing facility in DeSmet in anticipation of a large and rapid growth in pen needle demand. Therefore future capacity additions to UltiMed’s DeSmet pen needle production can be done rapidly and efficiently.

UltiMed, Inc., headquartered in St. Paul, Minnesota, manufactures diabetic drug delivery and specialty safety syringe devices, including insulin syringes, pen needles and specialty safety syringes for both the domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world. UltiMed, Inc. is a leader in safe needle disposal, and offers their full-line of diabetic insulin syringes and pen needles in a patented UltiGuard™ dual- use packaging style. The exclusive packaging style combines premium quality needles and an approved sharps container all in one system.

UltiMed, Inc. announces the promotion of Brahim Zabeli to Sr. Vice President

  • March 10, 2011
  • Corporate News

St. Paul, MN – March 9, 2011 – UltiMed, Inc. announced today the promotion of Brahim Zabeli to Sr. Vice President of Sales and Marketing.

Mr. Zabeli has served as the Vice President of U.S. Diabetes Care division since September 2010. In his new capacity, Zabeli will oversee all marketing and sales management programs.

UltiMed, Inc., headquartered in St. Paul, Minnesota, manufactures diabetic drug delivery and specialty safety syringe devices, including insulin syringes, pen needles and specialty safety syringes for both the domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world. UltiMed, Inc. is a leader in safe needle disposal, and offers their full-line of diabetic insulin syringes and pen needles in a patented UltiGuard™ dual- use packaging style. The exclusive packaging style combines premium quality needles and an approved sharps container all in one system.

UltiMed, Inc. Announces New Product Launch of 50-Count Pen Needle

  • March 04, 2011
  • Corporate News

St. Paul, MN – March 3, 2011 – UltiMed, Inc. announces the launch of a new 50-count pen needle.

Traditionally pen needles have been dispensed in quantities of 100; however, one of the world’s largest retailers currently offers a 50-count pen needle under their private-label brand. The launch of UltiMed’s new 50-count pen needle opens up distribution for a high quality cost effective pen needle to all retail and independent pharmacies. Over the past decade many diabetes patients have seen their co-pays rise to a point where it may actually be less expensive to simply buy their pen needles with cash. UltiMed’s products are covered by most insurance plans, so for those that have good insurance coverage they can continue to pay their co-pay.

The new easy-dispense box was designed with the consumer and pharmacist in mind. The unique design makes it easy for patients to dispense their pen needles. It also allows pharmacists several ways to display the product and whichever option they choose, the essential information needed to fill a patient’s prescription is always highly visible.

UltiMed, Inc. manufactures their premium quality universal-fit pen needles in their De Smet, South Dakota factory and offers the only U.S. assembled pen needle. Their products allow pharmacists to offer diabetes patients all the comfort of the leading brand while increasing their profit margins.

UltiMed, Inc., headquartered in St. Paul, Minnesota, manufactures diabetic drug delivery devices, including insulin syringes and pen needles for both the domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world.

UltiMed, Inc. introduces new Insulin Safety Syringe line

  • February 10, 2011
  • Corporate News

St. Paul, MN – February 19, 2011 – UltiMed, Inc. announced today the introduction of the new UltiCare® Insulin Safety Syringe line.

The UltiCare safety-engineered insulin syringes are a premium quality, low-cost alternative that protect both the patient and healthcare provider. The low dead space design technology reduces medication waste and cost by precisely and accurately delivering each dose. The introduction of the UltiCare Insulin Safety Syringe fills a void in a competitive market and offers customers an alternative safety insulin syringe. UltiMed, Inc. continues to be an innovative leader in specialty low dead space syringe development.

UltiMed, Inc., headquartered in St. Paul, Minnesota, manufactures diabetic drug delivery and specialty safety syringe devices, including insulin syringes, pen needles and specialty safety syringes for both the domestic and international markets. The company owns and operates two state of the art medical device-manufacturing facilities in the U.S. and abroad. UltiMed, Inc. has a wide range of global business partners to assist in bringing its broad spectrum of medical products to customers around the world. UltiMed, Inc. is a leader in safe needle disposal, and offers their full-line of diabetic insulin syringes and pen needles in a patented UltiGuard™ dual- use packaging style. The exclusive packaging style combines premium quality needles and an approved sharps container all in one system.